EuBiologics Co Ltd
KOSDAQ:206650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EuBiologics Co Ltd
Cash Taxes Paid
EuBiologics Co Ltd
Cash Taxes Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Taxes Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
EuBiologics Co Ltd
KOSDAQ:206650
|
Cash Taxes Paid
₩1.5B
|
CAGR 3-Years
674%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Cash Taxes Paid
₩443.9B
|
CAGR 3-Years
27%
|
CAGR 5-Years
47%
|
CAGR 10-Years
36%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Cash Taxes Paid
₩1.7B
|
CAGR 3-Years
75%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Cash Taxes Paid
₩142.4m
|
CAGR 3-Years
422%
|
CAGR 5-Years
88%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Cash Taxes Paid
₩341m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
67%
|
CAGR 10-Years
27%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Cash Taxes Paid
₩112.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EuBiologics Co Ltd
Glance View
EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 323 full-time employees. The company went IPO on 2017-01-24. The firm operates its business through two segments. The Vaccine segment manufactures and sells oral cholera vaccines. The Contract Research and Manufacturing Organization (CRMO) segment contracts, researches and manufactures biopharmaceuticals.
See Also
What is EuBiologics Co Ltd's Cash Taxes Paid?
Cash Taxes Paid
1.5B
KRW
Based on the financial report for Dec 31, 2025, EuBiologics Co Ltd's Cash Taxes Paid amounts to 1.5B KRW.
What is EuBiologics Co Ltd's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 3Y
674%
Over the last year, the Cash Taxes Paid growth was 47%. The average annual Cash Taxes Paid growth rates for EuBiologics Co Ltd have been 674% over the past three years .
